Apoptosis-related microRNA changes in the right atrium induced by remote ischemic perconditioning during valve

Qinghua Hu1, Wanjun Luo1, Lingjin Huang1

  • 1Department of cardiovascular surgery, Xiangya Hospital, Central-South University, Changsha, Hunan, China, 410078.

Scientific Reports
|January 8, 2016
PubMed

Insights

Remote ischemic perconditioning (RIPerc) reduces apoptosis in atrial myocardium during cardiac surgery. This cardioprotective effect involves downregulation of miR-1 and miR-195, impacting Bcl-2 expression.

Area of Science:

  • Cardiology
  • Molecular Biology
  • Cellular Biology

Background:

  • Remote ischemic preconditioning (RIPerc) attenuates myocardial injury during cardiac surgery.
  • MicroRNAs (miRs) play a critical role in myocardial ischemia/reperfusion (I/R) injury and apoptosis.

Purpose of the Study:

  • To investigate RIPerc's effect on atrial myocardium apoptosis during valve replacement surgery.
  • To identify specific apoptosis-related miRs involved in RIPerc's cardioprotective mechanism.

Main Methods:

  • Quantitative reverse transcription polymerase chain reaction (qRT-PCR) to measure miR expression.
  • Western blotting to assess protein levels of target genes, including Bcl-2 and programmed cell death 4 (PDCD4).

Main Results:

  • RIPerc significantly inhibited atrial myocardium apoptosis during cardiac ischemia.
  • Seventeen miRs showed altered expression post-ischemia; 9 apoptosis-related miRs, including miR-1, miR-21, miR-24, and miR-195, exhibited differential expression in the RIPerc group.
  • miR-1 and miR-195 were downregulated, leading to the upregulation of their target gene Bcl-2 in the RIPerc group. No significant changes were observed for miR-21, miR-24, or PDCD4.

Conclusions:

  • RIPerc confers cardioprotection by reducing atrial apoptosis during cardiac surgery.
  • Specific miRs, notably miR-1 and miR-195, are implicated in the anti-apoptotic effects of RIPerc, likely through modulation of Bcl-2 expression.

Related Concept Videos